Michael Sinclair - 13 Jun 2022 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC.

Role
Director, 10%+ Owner
Signature
/s/ Michael Sinclair
Issuer symbol
N/A
Transactions as of
13 Jun 2022
Net transactions value
-$149,188
Form type
4
Filing time
15 Jun 2022, 16:30:45 UTC
Previous filing
13 Jun 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Sale $60,895 -5,491 -17% $11.09 27,345 13 Jun 2022 Direct
transaction OPNT Common Stock Sale $78,752 -7,225 -26% $10.90 20,120 14 Jun 2022 Direct
transaction OPNT Common Stock Sale $9,540 -900 -4.5% $10.60 19,220 15 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.